GSK
Website: GSK
Index: FTSE 100
EPIC: GSK
Sector: Pharmaceuticals & Biotechnology
Subsector: Pharmaceuticals
Market Cap:
£60.2B
Payout Frequency: Quarterly
GSK Annual Dividend Yield - 3.16%
Dividends Used in Calculation:
14/11/2024 |
09/01/2025 |
Q3 |
15.00p |
GBX |
20/02/2025 |
10/04/2025 |
Q4 |
16.00p |
GBX |
15/05/2025 |
10/07/2025 |
Q1 |
16.00p |
GBX |
Total (Annual Dividends Per Share):
47.00p
Dividend Yield = Annual Dividends Per Share (47.00p) ÷ Share Price (1485p) = 3.16%
GSK Dividend History
15/05/2025 | 10/07/2025 | Q1 | 16.00p | GBX |
20/02/2025 | 10/04/2025 | Q4 | 16.00p | GBX |
14/11/2024 | 09/01/2025 | Q3 | 15.00p | GBX |
15/08/2024 | 10/10/2024 | Q2 | 15.00p | GBX |
16/05/2024 | 11/07/2024 | Q1 | 15.00p | GBX |
22/02/2024 | 11/04/2024 | Q4 | 16.00p | GBX |
16/11/2023 | 11/01/2024 | Q3 | 14.00p | GBX |
17/08/2023 | 12/10/2023 | Q2 | 14.00p | GBX |
18/05/2023 | 13/07/2023 | Q1 | 14.00p | GBX |
23/02/2023 | 13/04/2023 | Q4 | 13.75p | GBX |
17/11/2022 | 12/01/2023 | Q3 | 13.75p | GBX |
18/08/2022 | 06/10/2022 | Q2 | 16.25p | GBX |
19/05/2022 | 01/07/2022 | Q1 | 14.00p | GBX |
24/02/2022 | 07/04/2022 | Q4 | 23.00p | GBX |
18/11/2021 | 13/01/2022 | Q3 | 19.00p | GBX |
19/08/2021 | 07/10/2021 | Q2 | 19.00p | GBX |
20/05/2021 | 08/07/2021 | Q1 | 19.00p | GBX |
18/02/2021 | 08/04/2021 | Q4 | 23.00p | GBX |
12/11/2020 | 14/01/2021 | Q3 | 19.00p | GBX |
13/08/2020 | 08/10/2020 | Q2 | 19.00p | GBX |
14/05/2020 | 09/07/2020 | Q1 | 19.00p | GBX |
20/02/2020 | 09/04/2020 | Q4 | 23.00p | GBX |
14/11/2019 | 09/01/2020 | Q3 | 19.00p | GBX |
08/08/2019 | 10/10/2019 | Q2 | 19.00p | GBX |
16/05/2019 | 11/07/2019 | Q1 | 19.00p | GBX |
21/02/2019 | 11/04/2019 | Q4 | 23.00p | GBX |
15/11/2018 | 10/01/2019 | Q3 | 19.00p | GBX |
09/08/2018 | 11/10/2018 | Q2 | 19.00p | GBX |
10/05/2018 | 12/07/2018 | Q1 | 19.00p | GBX |
22/02/2018 | 12/04/2018 | Q4 | 23.00p | GBX |
09/11/2017 | 11/01/2018 | Q3 | 19.00p | GBX |
10/08/2017 | 12/10/2017 | Q2 | 19.00p | GBX |
11/05/2017 | 13/07/2017 | Q1 | 19.00p | GBX |
23/02/2017 | 13/04/2017 | Q4 | 23.00p | GBX |
03/11/2016 | 12/01/2017 | Q3 | 19.00p | GBX |
11/08/2016 | 13/10/2016 | Q2 | 19.00p | GBX |
12/05/2016 | 14/07/2016 | Q1 | 19.00p | GBX |
18/02/2016 | 14/04/2016 | Q4 | 23.00p | GBX |
18/02/2016 | 14/04/2016 | Special | 20.00p | GBX |
12/11/2015 | 14/01/2016 | Q3 | 19.00p | GBX |
13/08/2015 | 01/10/2015 | Q2 | 19.00p | GBX |
14/05/2015 | 09/07/2015 | Q1 | 19.00p | GBX |
19/02/2015 | 09/04/2015 | Q4 | 23.00p | GBX |
06/11/2014 | 08/01/2015 | Q3 | 19.00p | GBX |
06/08/2014 | 02/10/2014 | Q2 | 19.00p | GBX |
14/05/2014 | 10/07/2014 | Q1 | 19.00p | GBX |
19/02/2014 | 10/04/2014 | Q4 | 23.00p | GBX |
13/11/2013 | 09/01/2014 | Q3 | 19.00p | GBX |
07/08/2013 | 03/10/2013 | Q2 | 18.00p | GBX |
08/05/2013 | 11/07/2013 | Q1 | 18.00p | GBX |
2024 | | 15.000 | 15.000 | 15.000 | 16.000 | GBX | 61.000 | 9.41 |
2023 | | 14.000 | 14.000 | 14.000 | 13.750 | GBX | 55.750 | -16.79 |
2022 | | 14.000 | 16.250 | 13.750 | 23.000 | GBX | 67.000 | -16.25 |
2021 | | 19.000 | 19.000 | 19.000 | 23.000 | GBX | 80.000 | 0.00 |
2020 | | 19.000 | 19.000 | 19.000 | 23.000 | GBX | 80.000 | 0.00 |
2019 | | 19.000 | 19.000 | 19.000 | 23.000 | GBX | 80.000 | 0.00 |
2018 | | 19.000 | 19.000 | 19.000 | 23.000 | GBX | 80.000 | 0.00 |
2017 | | 19.000 | 19.000 | 19.000 | 23.000 | GBX | 80.000 | -20.00 |
2016 | 20.000 | 19.000 | 19.000 | 19.000 | 23.000 | GBX | 100.000 | 25.00 |
2015 | | 19.000 | 19.000 | 19.000 | 23.000 | GBX | 80.000 | 0.00 |
2014 | | 19.000 | 19.000 | 19.000 | 23.000 | GBX | 80.000 | 45.45 |
2013 | | 18.000 | 18.000 | 19.000 | | GBX | 55.000 | |
GSK Dividend Calculator
GSK Dividend Growth
Dividend Growth (1Y) |
5.08%
|
Dividend CAGR (5Y) |
-9.12%
|
Years of Growth |
1
|
Payout Ratio |
78.91%
|
Buyback Yield |
-0.73%
|
Shareholder Yield |
3.29%
|
GSK Valuation & Profitability
P/E Ratio (TTM) |
19.51
|
Forward P/E |
8.73
|
P/FCF |
–
|
Earnings Yield |
5.24%
|
FCF Yield |
8.94%
|
ROE |
27.1%
|
ROCE |
15.68%
|
Profit Margin |
10%
|
Operating Margin |
19.83%
|
Gross Margin |
71.92%
|